Michael Joseph Golembiewski serves as Executive at PERNIX THERAPEUTICS HOLDINGS, INC., where they oversee executive responsibilities. Since joining the company, Michael Joseph Golembiewski has executed 6 insider transactions totaling $100.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 29, 2024 involved receiving (via award) 417 shares valued at $459.
Michael Joseph Golembiewski currently holds 86,869 shares of PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Joseph Golembiewski has been a net buyer of PTX stock. They have purchased $100.4K and sold $0 worth of shares.
Michael Joseph Golembiewski's most recent insider trade was on Feb 29, 2024, when they sold 417 shares at $1.10 per share.
Get notified when new Form 4 filings are submitted
| $1.21 |
| Discretionary |
| Aug 31, 2023 | SEEL | $7.8K | Award | 12,500 | $0.62 | Discretionary |
| Feb 28, 2023 | SEEL | $8.4K | Award | 12,500 | $0.67 | Discretionary |
| Feb 28, 2022 | SEEL | $11.3K | Award | 12,500 | $0.90 | Discretionary |
| Aug 8, 2017 | PTX | $0 | Award | 3,300 | $N/A | Discretionary |